Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. scores highest on Earnings (88) and lowest on Price (5). Its PosiPenta is 58.40 out of 100, around the middle of similar companies.
On the Penta Grid this week, Eton Pharmaceuticals, Inc. is Grid #164 of 836 in the Healthcare sector in United States, and Grid #815 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. | 58.40 | 5 | 88 | 81 | 61 | 56 |
| Ocular Therapeutix, Inc. | 35.41 | 22 | 31 | 35 | 42 | 47 |
| Korsana Biosciences, Inc. | 41.54 | 0 | 34 | 61 | 76 | 37 |
| Nutex Health Inc. | 63.91 | 63 | 57 | 84 | 61 | 54 |
| Pacira BioSciences, Inc. | 66.05 | 32 | 88 | 99 | 52 | 58 |
| Tyra Biosciences, Inc. | 40.29 | 18 | 23 | 44 | 61 | 54 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 125.78 |
| P/B ratio | 30.87 |
EEarnings
| Trailing EPS | ₹37.89 |
| Forward EPS | ₹241.52 |
NNitro
| Price | 4765.11 |
| 52-week high | 6286.23 |
| 52-week low | 1351.58 |
| Fall from 52-week high | 24.2% |
TTorque
| Return on equity (ROE) | 35.97% |
| Debt-to-equity | 0.63 |
AAnchor
| Beta (price swings) | 0.90 |
| Market cap | ₹13,620 Cr |
| Insider holding | 4.89% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Eton Pharmaceuticals, Inc.'s PosiPenta score?
Eton Pharmaceuticals, Inc.'s PosiPenta is 58.40 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Eton Pharmaceuticals, Inc. stand on the Penta Grid?
On the Penta Grid this week, Eton Pharmaceuticals, Inc. is Grid #164 of 836 in the Healthcare sector in United States, and Grid #815 of 3,999 in United States.
Which PosiPenta pillar is strongest for Eton Pharmaceuticals, Inc.?
Earnings (growth), with a score of 88 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Eton Pharmaceuticals, Inc.?
Price (valuation), with a score of 5 out of 100: much weaker than most similar companies.
Has Eton Pharmaceuticals, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.42 points, from 56.98 to 58.40.
PositoAI is for research and education only and is not investment advice.